Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

Completed

• Conditions: GERD

• Registration Number: NCT00884247
• Lead Sponsor: AstraZeneca

Brief Summary

The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-04
• Study First Submitted: 2009-04-17
• Study First Submitted QC: 2009-04-17
• Study First Posted: 2009-04-20
• Study Completion: 2009-06
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-06
• Last Update Posted: 2010-12-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• Female and/or male aged > 18 years
• Diagnosis of GERD confirmed
• Prescription of GERD treatment or already receiving GERD treatment

Exclusion Criteria

• Any symptom suggesting a need for further investigation
• Previous participation in the present study
• Current participation in a clinical study or participation in a clinical study during the last 30 days

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Research Site; 🇸🇪 Hälsocenter, Södertälje, Sweden